Matches in Wikidata for { <http://www.wikidata.org/entity/Q73624882> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q73624882 description "artículu científicu espublizáu en setiembre de 1997" @default.
- Q73624882 description "im September 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73624882 description "scientific article published on 01 September 1997" @default.
- Q73624882 description "wetenschappelijk artikel" @default.
- Q73624882 description "наукова стаття, опублікована у вересні 1997" @default.
- Q73624882 name "Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome" @default.
- Q73624882 name "Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome" @default.
- Q73624882 type Item @default.
- Q73624882 label "Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome" @default.
- Q73624882 label "Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome" @default.
- Q73624882 prefLabel "Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome" @default.
- Q73624882 prefLabel "Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome" @default.
- Q73624882 P1433 Q73624882-B40770F4-922D-44B5-8F52-511F2DC8FCFC @default.
- Q73624882 P1476 Q73624882-612C23DC-E427-4946-AD62-8CDC6D3B069A @default.
- Q73624882 P2093 Q73624882-04FDE30A-FFE4-40F2-AF94-870E50EBF68E @default.
- Q73624882 P2093 Q73624882-C3F0CC9D-7741-4CF1-89D4-86F9EF3937E2 @default.
- Q73624882 P2093 Q73624882-D5904F1C-3833-4249-A87E-9CD284CAC9C0 @default.
- Q73624882 P2093 Q73624882-E7953E45-83AD-474A-9893-EF2EBCB11999 @default.
- Q73624882 P304 Q73624882-3A99EE71-D7B8-49A5-B80C-6FEA87678DAF @default.
- Q73624882 P31 Q73624882-5F1BF7F8-0782-4F18-A1B5-EBFA3C80C0C0 @default.
- Q73624882 P356 Q73624882-0AFEF34F-B8B8-44B9-979B-6D1D86B337DA @default.
- Q73624882 P433 Q73624882-6E2C6409-A3E9-4B4E-8997-256274A4D6F9 @default.
- Q73624882 P478 Q73624882-615FC371-E8F1-4FC5-AC5D-24205D2575A9 @default.
- Q73624882 P577 Q73624882-EEF98536-2BEA-4F29-89AD-7D47A792E286 @default.
- Q73624882 P698 Q73624882-87463AA6-1CBB-4D4E-9189-BE874861529A @default.
- Q73624882 P921 Q73624882-2C3AE138-3C39-48D5-BE5A-AC7E5F263FD9 @default.
- Q73624882 P921 Q73624882-8866ECE4-BC86-4A55-A768-535DE617F492 @default.
- Q73624882 P356 (SICI)1097-4598(199709)20:9%3C1146::AID-MUS9%3E3.0.CO;2-8 @default.
- Q73624882 P698 9270671 @default.
- Q73624882 P1433 Q15764281 @default.
- Q73624882 P1476 "Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome" @default.
- Q73624882 P2093 "D S Kim" @default.
- Q73624882 P2093 "G C Claussen" @default.
- Q73624882 P2093 "S J Oh" @default.
- Q73624882 P2093 "T C Head" @default.
- Q73624882 P304 "1146-1152" @default.
- Q73624882 P31 Q13442814 @default.
- Q73624882 P356 "10.1002/(SICI)1097-4598(199709)20:9<1146::AID-MUS9>3.0.CO;2-8" @default.
- Q73624882 P433 "9" @default.
- Q73624882 P478 "20" @default.
- Q73624882 P577 "1997-09-01T00:00:00Z" @default.
- Q73624882 P698 "9270671" @default.
- Q73624882 P921 Q1756898 @default.
- Q73624882 P921 Q419472 @default.